A retrospective multicentric cohort study of checkpoint inhibitors‐induced pruritus with focus on management
Photodermatology, Photoimmunology & Photomedicine · 2023-09 · 39 (5) · 506-511
DOI: 10.1111/phpp.12892 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Photodermatology, Photoimmunology & Photomedicine, online erschienen am 12.06.2023. Verfasst von Chryssoula Papageorgiou und 17 weiteren Autor:innen. Beteiligte Einrichtung: Second Dermatology Department, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Ultraviolet Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
Limited data on immune checkpoint inhibitor (ICI)‐induced pruritus per se and efficacy of different therapeutic modalities in its management exist.
Objective
To study the quantitative and qualitative characteristics of ICI‐induced pruritus per se and to assess the efficacy of the therapeutic modalities usually applied.
Methods
We retrospectively reviewed the records of 91 patients who were under treatment with ICIs for any kind of neoplasia and developed pruritus during treatment.
Results
Twenty out of 91 individuals (22.0%) with ICI‐induced pruritus had pruritus as the only symptom, while 71/91 (78.0%) presented with pruritus coexisting with an additional cutaneous toxicity. Pruritus was treated with antihistamines (18/20, 90.0%) and/or topical regimens, as first‐line choice. In resistant cases, as a second therapeutic intervention, narrow‐band UVB (NBUVB), oral steroids and GABA analogs were added (70.0%). Statistical analysis revealed a significant difference in mean pruritus Numerical Rating Scale (NRS) scores between baseline and sequential visits. Moreover, subgroup analysis revealed a significant reduction in mean NRS scores in those treated with phototherapy.
Limitations
Retrospective design, low number of patients and survivorship bias.
Conclusion
Pruritus per se was present in a substantial portion of our cohort (22.0%). Our study confirms the efficacy of current treatment strategies and suggests NBUVB as a potential steroid‐sparing therapeutic alternative.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Second Dermatology Department, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- Department of Medical Oncology, School of Medicine, Faculty of Health Sciences, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece.
- Department of Dermatology and Venereology, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria.
- First Dermatology Department, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
ORCID-Profile: Vasiliki Nikolaou, Evangelos Karamitrousis, Zoe Apalla
Zitieren
APA
Papageorgiou, C., Lazaridou, E., Lallas, K., Papaioannou, K., Nikolaou, V., Mateeva, V., Efthymiadis, K., Koukoutzeli, C., Loga, K., Sogka, E., Karamitrousis, E., Lazaridis, G., Dionysopoulos, D., Lallas, A., Kemanetzi, C., Fotiadou, C., Timotheadou, E., & Apalla, Z. (2023). A retrospective multicentric cohort study of checkpoint inhibitors‐induced pruritus with focus on management. Photodermatology, Photoimmunology & Photomedicine, 39(5), 506-511. https://doi.org/10.1111/phpp.12892
Vancouver
Papageorgiou C, Lazaridou E, Lallas K, Papaioannou K, Nikolaou V, Mateeva V, et al. A retrospective multicentric cohort study of checkpoint inhibitors‐induced pruritus with focus on management. Photodermatology, Photoimmunology & Photomedicine. 2023;39(5):506-511. doi:10.1111/phpp.12892
BibTeX
@article{Papageorgiou2023,
author = {Papageorgiou, Chryssoula and Lazaridou, Elizabeth and Lallas, Konstantinos and Papaioannou, Kyparissos and Nikolaou, Vasiliki and Mateeva, Valeria and Efthymiadis, Konstantinos and Koukoutzeli, Chrysanthi and Loga, Konstantia and Sogka, Eleni and Karamitrousis, Evangelos and Lazaridis, George and Dionysopoulos, Dimitrios and Lallas, Aimilios and Kemanetzi, Christina and Fotiadou, Christina and Timotheadou, Eleni and Apalla, Zoe},
title = {A retrospective multicentric cohort study of checkpoint inhibitors‐induced pruritus with focus on management},
journal = {Photodermatology, Photoimmunology & Photomedicine},
year = {2023},
volume = {39},
number = {5},
pages = {506--511},
doi = {10.1111/phpp.12892}
}
EUVIMED